Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Basic Research in Cardiology|November 14, 2007
Adenosine: trigger and mediator of cardioprotectionMichael V Cohen, James M DowneyInternational Journal of Molecular Sciences|May 25, 2024
Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 AssemblyMichael V Cohen, James M DowneyJournal of Molecular and Cellular Cardiology|October 4, 2005
Unraveling the mysteries of classical preconditioningJames M Downey, Michael V CohenProgress in Cardiovascular Diseases|April 22, 2006
Reducing infarct size in the setting of acute myocardial infarctionJames M Downey, Michael V CohenCirculation Journal : Official Journal of the Japanese Circulation Society|June 10, 2009
Why do we still not have cardioprotective drugs?James M Downey, Michael V CohenAntioxidants & Redox Signaling|June 4, 2010
Ischemic postconditioning: from receptor to end-effectorMichael V Cohen, James M DowneyJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice?Michael V Cohen, James M DowneyBritish Journal of Pharmacology|September 11, 2014
Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the futureMichael V Cohen, James M DowneyJournal of Cardiovascular Pharmacology and Therapeutics|October 25, 2019
What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?Michael V Cohen, James M DowneyJournal of Cardiovascular Pharmacology and Therapeutics|December 4, 2013
Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor orderedMichael V Cohen, James M DowneyPageof 12